Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62392860fe6e9b129e232039273daa74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_763fc0113ef73f5c7fa40bd6b8453ba0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ff183af83c1a0a7cd08d56d8733541c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e36c5b86477d08e37820b3f85c42a68a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e53c195366c3f8f5655283e8c9437fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_418a47cbc9a08d8fa543068ba274234a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-71 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N37-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate |
2005-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_006c4a8b84d63c486ae294646c4ae3fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b5694fa90940c1d9755ac00fa424063 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44318dba07b2c40b525d636e5e2521da http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5986b75c085aa7a8d7c790286bfc2b0e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0dc0cb745d7b9c7ded3817db6a6ae559 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66e99ad267d87acc184d8c0215dd5ada |
publicationDate |
2007-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2007148711-A1 |
titleOfInvention |
Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-alpha |
abstract |
The invention discloses a previously unidentified subset of mammalian non-small cell lung carcinomas (NSCLC) in which platelet-derived growth factor receptor alpha (PDGFRα) is expressed and is driving the disease, and provides methods for identifying a mammalian NSCLC tumor that belongs to a subset of NSCLC tumors in which PDGFRα is expressed, and for identifying a NSCLC tumor that is likely to respond to a PDGFRα-inhibiting therapeutic. The invention also provides methods for inhibiting the progression of a mammalian NSCLC tumor in which PDGFRα is expressed, and for determining whether a compound inhibits the progression of a PDGFRα-expressing mammalian NSCLC tumor. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017161531-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010216718-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8962268-B2 |
priorityDate |
2005-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |